Homocysteine Induces Inflammation in Retina and Brain

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2020 Mar 7

PMID 32138265

Citations 55

Authors

Nehal M Elsherbiny

Isha Sharma

Dina Kira

Suhib Alhusban

Yara A Samra

Ravirajsinh Jadeja

Pamela Martin

Mohamed Al-Shabrawey

Amany Tawfik

Affiliations

Soon will be listed here.

Abstract

Homocysteine (Hcy) is an amino acid that requires vitamins B and folic acid for its metabolism. Vitamins B and folic acid deficiencies lead to hyperhomocysteinemia (HHcy, elevated Hcy), which is linked to the development of diabetic retinopathy (DR), age-related macular degeneration (AMD), and Alzheimer's disease (AD). The goal of the current study was to explore inflammation as an underlying mechanism of HHcy-induced pathology in age related diseases such as AMD, DR, and AD. Mice with HHcy due to a lack of the enzyme cystathionine-β-synthase (CBS) and wild-type mice were evaluated for microglia activation and inflammatory markers using immuno-fluorescence (IF). Tissue lysates isolated from the brain hippocampal area from mice with HHcy were evaluated for inflammatory cytokines using the multiplex assay. Human retinal endothelial cells, retinal pigment epithelial cells, and monocyte cell lines treated with/without Hcy were evaluated for inflammatory cytokines and NFκB activation using the multiplex assay, western blot analysis, and IF. HHcy induced inflammatory responses in mouse brain, retina, cultured retinal, and microglial cells. NFκB was activated and cytokine array analysis showed marked increase in pro-inflammatory cytokines and downregulation of anti-inflammatory cytokines. Therefore, elimination of excess Hcy or reduction of inflammation is a promising intervention for mitigating damage associated with HHcy in aging diseases such as DR, AMD, and AD.

Citing Articles

Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.

Shi M, Zheng J, Liu Y, Mao X, Wu X, Chu M J Am Heart Assoc. 2024; 13(19):e036527.

PMID: 39291496 PMC: 11681484. DOI: 10.1161/JAHA.124.036527.

Dihydroergotamine and Bromocriptine: Potential Drugs for the Treatment of Major Depressive Disorder and Alzheimer's Disease Comorbidity.

Fu M, Wang Q, Gao L, Ma Q, Wang J Mol Neurobiol. 2024; 62(2):2493-2514.

PMID: 39134826 DOI: 10.1007/s12035-024-04416-w.

Retinal Vein Occlusion-Background Knowledge and Foreground Knowledge Prospects-A Review.

Lendzioszek M, Bryl A, Poppe E, Zorena K, Mrugacz M J Clin Med. 2024; 13(13).

PMID: 38999513 PMC: 11242360. DOI: 10.3390/jcm13133950.

Unraveling the Hippocampal Molecular and Cellular Alterations behind Tramadol and Tapentadol Neurobehavioral Toxicity.

Soares-Cardoso C, Leal S, Sa S, Dantas-Barros R, Dinis-Oliveira R, Faria J Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931463 PMC: 11206790. DOI: 10.3390/ph17060796.

Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions.

Li J, Sun W, Zhu X, Mei Y, Li W, Li J Metabolites. 2024; 14(6).

PMID: 38921477 PMC: 11205546. DOI: 10.3390/metabo14060343.

References

Minty A, Chalon P, Derocq J, Dumont X, Guillemot J, Kaghad M . Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 1993; 362(6417):248-50. DOI: 10.1038/362248a0. View

Phelip J, Ducros V, Faucheron J, Flourie B, Roblin X . Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007; 14(2):242-8. DOI: 10.1002/ibd.20309. View

Kamat P, Kyles P, Kalani A, Tyagi N . Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder. Mol Neurobiol. 2015; 53(4):2451-2467. PMC: 4662933. DOI: 10.1007/s12035-015-9212-4. View

Rhodehouse B, Mayo J, Beard Jr R, Chen C, Bearden S . Opening of the blood-brain barrier before cerebral pathology in mild hyperhomocysteinemia. PLoS One. 2013; 8(5):e63951. PMC: 3655957. DOI: 10.1371/journal.pone.0063951. View

Tawfik A, Markand S, Al-Shabrawey M, Mayo J, Reynolds J, Bearden S . Alterations of retinal vasculature in cystathionine-β-synthase heterozygous mice: a model of mild to moderate hyperhomocysteinemia. Am J Pathol. 2014; 184(9):2573-85. PMC: 4188277. DOI: 10.1016/j.ajpath.2014.05.018. View

Srivastav K, Saxena S, Mahdi A, Shukla R, Meyer C, Akduman L . Increased serum level of homocysteine correlates with retinal nerve fiber layer thinning in diabetic retinopathy. Mol Vis. 2016; 22:1352-1360. PMC: 5135738. View

Gokkusu C, Tulubas F, Unlucerci Y, Ozkok E, Umman B, Aydin M . Homocysteine and pro-inflammatory cytokine concentrations in acute heart disease. Cytokine. 2010; 50(1):15-8. DOI: 10.1016/j.cyto.2009.12.015. View

Zeng H, Tso M, Lai S, Lai H . Activation of nuclear factor-kappaB during retinal degeneration in rd mice. Mol Vis. 2008; 14:1075-80. PMC: 2426720. View

Karlstetter M, Scholz R, Rutar M, Wong W, Provis J, Langmann T . Retinal microglia: just bystander or target for therapy?. Prog Retin Eye Res. 2014; 45:30-57. DOI: 10.1016/j.preteyeres.2014.11.004. View

10.

Chen S, Dong Z, Cheng M, Zhao Y, Wang M, Sai N . Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke. J Neuroinflammation. 2017; 14(1):187. PMC: 5604224. DOI: 10.1186/s12974-017-0963-x. View

11.

Ganguly P, Alam S . Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015; 14:6. PMC: 4326479. DOI: 10.1186/1475-2891-14-6. View

12.

Mohamed R, Sharma I, Ibrahim A, Saleh H, Elsherbiny N, Fulzele S . Hyperhomocysteinemia Alters Retinal Endothelial Cells Barrier Function and Angiogenic Potential via Activation of Oxidative Stress. Sci Rep. 2017; 7(1):11952. PMC: 5607263. DOI: 10.1038/s41598-017-09731-y. View

13.

Ibrahim A, Mander S, Hussein K, Elsherbiny N, Smith S, Al-Shabrawey M . Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget. 2016; 7(8):8532-45. PMC: 4890985. DOI: 10.18632/oncotarget.7384. View

14.

Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A . Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016; 139(2):324-332. DOI: 10.1111/jnc.13766. View

15.

Smith A, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A . Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis. 2018; 62(2):561-570. PMC: 5836397. DOI: 10.3233/JAD-171042. View

16.

Baroni L, Bonetto C, Rizzo G, Bertola C, Caberlotto L, Bazzerla G . Association Between Cognitive Impairment and Vitamin B12, Folate, and Homocysteine Status in Elderly Adults: A Retrospective Study. J Alzheimers Dis. 2019; 70(2):443-453. DOI: 10.3233/JAD-190249. View

17.

Zhang Y, Chen K, Sloan S, Bennett M, Scholze A, OKeeffe S . An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014; 34(36):11929-47. PMC: 4152602. DOI: 10.1523/JNEUROSCI.1860-14.2014. View

18.

Ghosh S, Shang P, Yazdankhah M, Bhutto I, Hose S, Montezuma S . Activating the AKT2-nuclear factor-κB-lipocalin-2 axis elicits an inflammatory response in age-related macular degeneration. J Pathol. 2016; 241(5):583-588. PMC: 5357190. DOI: 10.1002/path.4870. View

19.

Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, MALINOW M . Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci U S A. 1995; 92(5):1585-9. PMC: 42564. DOI: 10.1073/pnas.92.5.1585. View

20.

Kinney J, Bemiller S, Murtishaw A, Leisgang A, Salazar A, Lamb B . Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018; 4:575-590. PMC: 6214864. DOI: 10.1016/j.trci.2018.06.014. View